Skip to content

CVSA

Covista Inc.

NYSE · Consumer Cyclical · Personal Products & Services · US

$128.58
+1.44%
Ask drillr

Year over year

Reported trailing growth

Revenue
+9.3%
EBITDA
+14.6%
EBIT
+14.6%
EPS
+21.0%
Free cash flow
+36.6%
Operating cash flow
+39.2%

Forward estimates

Based on analyst estimates

Revenue
+7.8%
EBITDA
+7.1%
EPS
+22.5%

Three-year CAGR

Revenue
+10.4%
EBITDA
+10.9%
EBIT
+19.2%
Net income
+37.4%
EPS
+49.8%
Free cash flow
+33.3%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026